VHT
Vanguard Health Care ETFETF · Sectors$316.40−$0.28 (-0.09%)as of market close, Aug 13, 2026
☾ After hours:$316.22+0.00%3:59 PM ET
VHT holdings (2026)
All 401 positions in Vanguard Health Care ETF, ranked by portfolio weight — led by LLY at 13.8%. Weights come from the fund's own SEC N-PORT filing and update daily with prices; positions in stocks ChartRow doesn't track still appear, ranked by weight, without returns. Not investment advice.
Weights are the May 31, 2026 SEC filing rolled forward on each holding's price move (as of market close, Aug 13, 2026) — an estimate of today, not the filed figure. Switch the table below to see them exactly as filed.
Holdings
401
positions in the latest filing
Largest holding
13.8%
LLY · estimated today
Top 10 weight
52%
concentration · estimated today
On ChartRow
93.0%
fund weight in tickers ChartRow tracks
Filed
May 31, 2026
SEC N-PORT report date
Top 10 holdings#
CompanyWeight1D
Sector weights#
SectorWeight
Healthcare
87.1%
Not on ChartRow
7.0%
Industrials
3.6%
Consumer Staples
1.7%
Technology
0.6%
Estimated portfolio characteristics#
P/E (trailing)
30.7
weighted harmonic
P/E (forward)
17.3
weighted harmonic
Median P/E
28.8
per member, trailing
P/B
4.8
weighted
Dividend yield
1.42%
weighted
Earnings growth
-16.0%
aggregate TTM, YoY
Avg market cap
$347B
weighted
Estimated by our own bottom-up analysis of the fund's SEC-filed holdings, covering 93% of portfolio weight (92% carries a valid trailing P/E). Funds publish similar figures on their own sites; ours are recomputed daily from public data.
VHT holdings by weight#
1–100 of 401Weightsthe May 31, 2026 filing rolled forward on price — an estimate (as of market close, Aug 13, 2026)
| # | Company | Weight | Price | 1D | YTD | 1Y | Mkt cap |
|---|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | 13.76% | $1,209.77 | -0.9% | +12.6% | +89.2% | $1.08T |
| 2 | JNJJohnson & Johnson | 8.81% | $262.13 | +0.5% | +26.7% | +51.7% | $632B |
| 3 | ABBVAbbVie Inc. | 6.27% | $250.84 | +0.8% | +9.8% | +26.3% | $443B |
| 4 | UNHUnitedHealth Group Incorporated Common Stock (DE) | 5.12% | $399.30 | -1.6% | +21.0% | +52.7% | $363B |
| 5 | MRKMerck & Co. Inc. | 4.76% | $135.58 | +2.0% | +28.8% | +68.8% | $335B |
| 6 | AMGNAmgen Inc. | 3.18% | $417.93 | +0.4% | +27.7% | +46.7% | $226B |
| 7 | TMOThermo Fisher Scientific Inc. | 3.17% | $596.04 | -1.2% | +2.9% | +24.8% | $220B |
| 8 | ABTAbbott Laboratories | 2.74% | $111.29 | +0.3% | -11.2% | -15.1% | $194B |
| 9 | GILDGilead Sciences Inc. | 2.43% | $138.14 | +1.7% | +12.5% | +15.1% | $171B |
| 10 | PFEPfizer Inc. | 2.16% | $26.80 | +1.8% | +7.6% | +8.7% | $153B |
| 11 | ISRGIntuitive Surgical Inc. | 2.01% | $401.34 | +0.0% | -29.1% | -16.1% | $142B |
| 12 | BMYBristol-Myers Squibb Company | 1.86% | $64.65 | +1.5% | +19.9% | +38.9% | $132B |
| 13 | VRTXVertex Pharmaceuticals Incorporated | 1.85% | $516.13 | -1.8% | +13.8% | +33.1% | $131B |
| 14 | DHRDanaher Corporation | 1.84% | $204.02 | -0.9% | -10.9% | -0.8% | $143B |
| 15 | CVSCVS Health Corporation | 1.71% | $95.02 | +0.3% | +19.7% | +45.0% | $122B |
| 16 | SYKStryker Corporation | 1.66% | $341.08 | -1.8% | -3.0% | -9.4% | $131B |
| 17 | MDTMedtronic plc. | 1.64% | $90.59 | -0.2% | -5.7% | -1.6% | $116B |
| 18 | MCKMcKesson Corporation | 1.50% | $856.87 | -2.5% | +4.5% | +30.0% | $100B |
| 19 | ELVElevance Health Inc. | 1.23% | $398.19 | -0.2% | +13.6% | +36.1% | $86B |
| 20 | REGNRegeneron Pharmaceuticals Inc. | 1.18% | $805.82 | +1.0% | +4.4% | +44.8% | $83B |
| 21 | BSXBoston Scientific Corporation | 1.08% | $51.71 | +0.6% | -45.8% | -49.6% | $75B |
| 22 | CIThe Cigna Group | 1.05% | $278.10 | +0.2% | +1.0% | -0.8% | $73B |
| 23 | HCAHCA Healthcare Inc. | 0.93% | $411.79 | -0.7% | -11.8% | +5.5% | $91B |
| 24 | CORCencora Inc. | 0.81% | $310.01 | -1.3% | -8.2% | +7.2% | $59B |
| 25 | CAHCardinal Health Inc. | 0.78% | $231.28 | -1.2% | +12.5% | +58.1% | $54B |
| 26 | EWEdwards Lifesciences Corporation | 0.76% | $92.56 | -0.5% | +8.6% | +20.3% | $53B |
| 27 | BDXBecton Dickinson and Company | 0.73% | $181.96 | -0.9% | +19.3% | +18.7% | $50B |
| 28 | HUMHumana Inc. | 0.66% | $384.97 | -1.0% | +50.3% | +40.0% | $46B |
| 29 | IDXXIDEXX Laboratories Inc. | 0.64% | $566.93 | -0.6% | -16.2% | -13.1% | $45B |
| 30 | AAgilent Technologies Inc. | 0.60% | $149.33 | +0.7% | +9.7% | +27.3% | $42B |
| 31 | IQVIQVIA Holdings Inc. | 0.58% | $241.53 | -0.1% | +7.2% | +29.9% | $40B |
| 32 | NTRANatera Inc. | 0.58% | $310.78 | -1.6% | +35.7% | +94.5% | $45B |
| 33 | WATWaters Corporation | 0.58% | $413.52 | -0.6% | +8.9% | +44.8% | $41B |
| 34 | VEEVVeeva Systems Inc. | 0.56% | $252.63 | +4.6% | +13.2% | -8.3% | $41B |
| 35 | DXCMDexCom Inc. | 0.51% | $91.51 | +0.8% | +37.9% | +14.1% | $35B |
| 36 | GEHCGE HealthCare Technologies Inc. Common Stock | 0.48% | $73.80 | +2.1% | -10.0% | -0.8% | $34B |
| 37 | ZTSZoetis Inc. | 0.47% | $75.83 | +3.1% | -39.7% | -49.4% | $31B |
| 38 | RMDResMed Inc. | 0.47% | $226.72 | +0.3% | -5.9% | -20.0% | $33B |
| 39 | RVMDRevolution Medicines Inc. | 0.46% | $201.93 | -1.6% | +153.5% | +472.7% | $43B |
| 40 | CNCCentene Corporation | 0.46% | $66.05 | -1.5% | +60.5% | +152.4% | $33B |
| 41 | BIIBBiogen Inc. | 0.44% | $210.61 | +0.8% | +19.7% | +63.4% | $31B |
| 42 | ALNYAlnylam Pharmaceuticals Inc. | 0.42% | $227.00 | +1.4% | -42.9% | -47.2% | $30B |
| 43 | ILMNIllumina Inc. | 0.42% | $192.59 | -0.2% | +46.8% | +97.8% | $29B |
| 44 | MTDMettler-Toledo International Inc. | 0.41% | $1,430.84 | -0.5% | +2.6% | +10.7% | $29B |
| 45 | INSMInsmed Incorporated | 0.38% | $126.31 | -4.5% | -27.4% | +3.5% | $28B |
| 46 | LHLabcorp Holdings Inc. | 0.38% | $322.78 | -0.2% | +28.7% | +19.9% | $26B |
| 47 | DGXQuest Diagnostics Incorporated | 0.37% | $236.13 | -0.7% | +36.1% | +32.2% | $26B |
| 48 | WSTWest Pharmaceutical Services Inc. | 0.35% | $346.04 | -1.8% | +25.8% | +44.2% | $24B |
| 49 | THCTenet Healthcare Corporation | 0.33% | $267.16 | +0.1% | +34.4% | +56.7% | $22B |
| 50 | STESTERIS plc (Ireland) | 0.33% | $236.07 | -0.2% | -6.9% | -3.2% | $23B |
| 51 | UTHRUnited Therapeutics Corporation | 0.29% | $501.11 | -2.1% | +2.8% | +66.3% | $21B |
| 52 | INCYIncyte Corp. | 0.28% | $120.49 | -0.2% | +22.0% | +47.6% | $24B |
| 53 | ZBHZimmer Biomet Holdings Inc. | 0.28% | $99.57 | +1.7% | +10.7% | -2.2% | $19B |
| 54 | MRNAModerna Inc. | 0.27% | $63.65 | -0.0% | +115.8% | +148.1% | $25B |
| 55 | VTRSViatris Inc. | 0.26% | $16.04 | -0.4% | +28.8% | +58.5% | $18B |
| 56 | GHGuardant Health Inc. | 0.25% | $159.62 | -3.3% | +56.3% | +189.7% | $21B |
| 57 | NBIXNeurocrine Biosciences Inc. | 0.21% | $150.80 | -3.6% | +6.3% | +17.0% | $15B |
| 58 | COOThe Cooper Companies Inc. | 0.21% | $76.62 | -0.1% | -6.5% | +5.4% | $15B |
| 59 | BAXBaxter International | 0.20% | $27.05 | +0.4% | +41.5% | +12.8% | $14B |
| 60 | CRLCharles River Laboratories | 0.20% | $281.17 | -1.1% | +41.0% | +84.1% | $13B |
| 61 | Vanguard Cmt Funds-Vanguard Market Liquidity Fund | 0.19% | — | — | — | — | — |
| 62 | ROIVRoivant Sciences Ltd. | 0.19% | $36.29 | +0.4% | +67.2% | +213.7% | $26B |
| 63 | SOLVSolventum Corporation | 0.19% | $86.49 | +1.4% | +9.1% | +20.0% | $15B |
| 64 | JAZZJazz Pharmaceuticals plc Common Stock (Ireland) | 0.19% | $245.84 | -1.2% | +44.6% | +116.9% | $16B |
| 65 | RVTYRevvity Inc. | 0.19% | $117.46 | -0.4% | +21.4% | +33.5% | $13B |
| 66 | MEDPMedpace Holdings Inc. | 0.19% | $581.47 | -2.6% | +3.5% | +26.6% | $16B |
| 67 | EXELExelixis Inc. | 0.18% | $50.59 | +0.4% | +15.4% | +33.3% | $13B |
| 68 | BMRNBioMarin Pharmaceutical Inc. | 0.18% | $68.50 | -2.5% | +15.3% | +20.5% | $13B |
| 69 | EHCEncompass Health Corporation | 0.18% | $123.48 | -1.1% | +16.3% | +4.1% | $12B |
| 70 | PENPenumbra Inc. | 0.17% | $326.94 | +0.1% | +5.2% | +31.5% | $13B |
| 71 | ALGNAlign Technology Inc. | 0.17% | $176.10 | +1.2% | +12.8% | +25.3% | $13B |
| 72 | HALOHalozyme Therapeutics Inc. | 0.17% | $100.67 | -1.1% | +49.6% | +57.2% | $11B |
| 73 | Ionis Pharmaceuticals Inc | 0.17% | — | — | — | — | — |
| 74 | BBIOBridgeBio Pharma Inc. | 0.17% | $81.22 | -3.1% | +6.2% | +65.5% | $16B |
| 75 | TECHBio-Techne | 0.16% | $72.18 | -0.1% | +22.7% | +36.6% | $11B |
| 76 | ELANElanco Animal Health Incorporated | 0.16% | $22.51 | +1.7% | -0.5% | +29.1% | $11B |
| 77 | GKOSGlaukos Corporation | 0.15% | $189.42 | +1.5% | +67.8% | +112.0% | $11B |
| 78 | MOHMolina Healthcare | 0.15% | $205.73 | -0.2% | +18.5% | +30.8% | $11B |
| 79 | ENSGThe Ensign Group Inc. | 0.15% | $181.98 | +0.2% | +4.5% | +11.3% | $11B |
| 80 | CORTCorcept Therapeutics Incorporated | 0.15% | $110.58 | -1.4% | +217.8% | +50.3% | $12B |
| 81 | ARWRArrowhead Pharmaceuticals Inc. | 0.15% | $85.63 | -1.9% | +29.0% | +381.1% | $12B |
| 82 | PODDInsulet Corporation | 0.15% | $146.34 | +0.9% | -48.5% | -52.7% | $10B |
| 83 | GMEDGlobus Medical Inc. | 0.14% | $85.95 | +0.3% | -1.6% | +38.9% | $12B |
| 84 | HSICHenry Schein | 0.14% | $90.12 | -0.7% | +19.2% | +33.5% | $10B |
| 85 | UHSUniversal Health Services | 0.13% | $171.19 | -0.7% | -21.5% | -2.3% | $10B |
| 86 | MDLNMedline Inc. | 0.13% | $35.58 | +0.2% | -15.3% | — | $31B |
| 87 | PRAXPraxis Precision Medicines Inc. | 0.12% | $368.47 | -4.6% | +25.0% | +660.4% | $10B |
| 88 | BTSGBrightSpring Health Services Inc. | 0.12% | $60.22 | +0.9% | +60.8% | +177.2% | $12B |
| 89 | CYTKCytokinetics Incorporated | 0.12% | $73.44 | -2.9% | +15.6% | +114.0% | $10B |
| 90 | Masimo Corp | 0.12% | — | — | — | — | — |
| 91 | HealthEquity Inc | 0.11% | — | — | — | — | — |
| 92 | MDGLMadrigal Pharmaceuticals Inc. | 0.11% | $507.08 | -5.4% | -12.9% | +41.2% | $12B |
| 93 | AXSMAxsome Therapeutics Inc. | 0.11% | $213.63 | -0.5% | +17.0% | +103.0% | $11B |
| 94 | DVADaVita Inc. | 0.10% | $179.09 | -1.3% | +57.6% | +35.6% | $11B |
| 95 | Krystal Biotech Inc | 0.10% | — | — | — | — | — |
| 96 | Repligen Corp | 0.09% | — | — | — | — | — |
| 97 | Alkermes PLC | 0.09% | — | — | — | — | — |
| 98 | Lantheus Holdings Inc | 0.09% | — | — | — | — | — |
| 99 | Bruker Corp | 0.09% | — | — | — | — | — |
| 100 | Avantor Inc | 0.09% | — | — | — | — | — |
Methodology#
Holdings and weights are sourced from the fund's portfolio as disclosed to the SEC on Form N-PORT — a public filing. Portfolio filings are quarterly (public ~60 days after quarter end), so we anchor on the latest one and roll each weight forward daily by that holding's price move, keeping the numbers current between filings; positions in stocks ChartRow doesn't track carry their filed weight unchanged and show "—" where we have no data. Returns are total returns (dividends reinvested). One row per company, not per ticker: when a fund holds more than one share class of the same company (Alphabet's GOOGL and GOOG, for example), we combine them into a single row whose weight is the sum of its classes. Past performance does not predict future returns; not investment advice.
FAQ#
- What are the top 10 holdings of VHT?
- VHT's top 10 holdings are Eli Lilly and Company (LLY), 13.8%; Johnson & Johnson (JNJ), 8.8%; AbbVie Inc. (ABBV), 6.3%; UnitedHealth Group Incorporated Common Stock (DE) (UNH), 5.1%; Merck & Co. Inc. (MRK), 4.8%; Amgen Inc. (AMGN), 3.2%; Thermo Fisher Scientific Inc. (TMO), 3.2%; Abbott Laboratories (ABT), 2.7%; Gilead Sciences Inc. (GILD), 2.4%; Pfizer Inc. (PFE), 2.2% — together about 52% of the fund, per its May 31, 2026 SEC filing with weights rolled forward to today.
- How many holdings does VHT have?
- Vanguard Health Care ETF (VHT) held 401 positions as of its latest SEC N-PORT filing (May 31, 2026).
- How current are VHT's holdings?
- Funds disclose their full portfolio to the SEC on Form N-PORT; the quarter-end report becomes public about 60 days later. ChartRow anchors on the latest public filing (May 31, 2026) and rolls each weight forward daily by that holding's price move, so the weights shown estimate today rather than the filing date.
- Is ChartRow affiliated with VHT or Vanguard?
- No. ChartRow is independent and is not affiliated with, sponsored by, or endorsed by Vanguard or Vanguard Health Care ETF. Everything on this page is derived independently from the fund's public SEC filings; fund names and trademarks belong to their owners. For information only — not investment advice.